Unit cost repositories for health program planning and evaluation: a report on research in practice with lessons learned.

Costs Developing countries Health financing Knowledge Resource allocation

Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
02 06 2023
Historique:
received: 30 09 2022
accepted: 22 05 2023
medline: 5 6 2023
pubmed: 2 6 2023
entrez: 1 6 2023
Statut: epublish

Résumé

Most low- and middle-income countries have limited access to cost data that meets the needs of health policy-makers and researchers in health intervention areas including HIV, tuberculosis, and immunization. Unit cost repositories (UCRs)-searchable databases that systematically codify evidence from costing studies-have been developed to reduce the effort required to access and use existing costing information. These repositories serve as public resources and standard references, which can improve the consistency and quality of resource needs projections used for strategic planning and resource mobilization. UCRs also enable analysis of cost determinants and more informed imputation of missing cost data. This report examines our experiences developing and using seven UCRs (two global, five country-level) for cost projection and research purposes. We identify advances, challenges, enablers, and lessons learned that might inform future work related to UCRs. Our lessons learned include: (1) UCRs do not replace the need for costing expertise; (2) tradeoffs are required between the degree of data complexity and the useability of the UCR; (3) streamlining data extraction makes populating the UCR with new data easier; (4) immediate reporting and planning needs often drive stakeholder interest in cost data; (5) developing and maintaining UCRs requires dedicated staff time; (6) matching decision-maker needs with appropriate cost data can be challenging; (7) UCRs must have data quality control systems; (8) data in UCRs can become obsolete; and (9) there is often a time lag between the identification of a cost and its inclusion in UCRs. UCRs have the potential to be a valuable public good if kept up-to-date with active quality control and adequate support available to end-users. Global UCR collaboration networks and greater control by local stakeholders over global UCRs may increase active, sustained use of global repositories and yield higher quality results for strategic planning and resource mobilization.

Sections du résumé

BACKGROUND
Most low- and middle-income countries have limited access to cost data that meets the needs of health policy-makers and researchers in health intervention areas including HIV, tuberculosis, and immunization. Unit cost repositories (UCRs)-searchable databases that systematically codify evidence from costing studies-have been developed to reduce the effort required to access and use existing costing information. These repositories serve as public resources and standard references, which can improve the consistency and quality of resource needs projections used for strategic planning and resource mobilization. UCRs also enable analysis of cost determinants and more informed imputation of missing cost data. This report examines our experiences developing and using seven UCRs (two global, five country-level) for cost projection and research purposes.
DISCUSSION
We identify advances, challenges, enablers, and lessons learned that might inform future work related to UCRs. Our lessons learned include: (1) UCRs do not replace the need for costing expertise; (2) tradeoffs are required between the degree of data complexity and the useability of the UCR; (3) streamlining data extraction makes populating the UCR with new data easier; (4) immediate reporting and planning needs often drive stakeholder interest in cost data; (5) developing and maintaining UCRs requires dedicated staff time; (6) matching decision-maker needs with appropriate cost data can be challenging; (7) UCRs must have data quality control systems; (8) data in UCRs can become obsolete; and (9) there is often a time lag between the identification of a cost and its inclusion in UCRs.
CONCLUSIONS
UCRs have the potential to be a valuable public good if kept up-to-date with active quality control and adequate support available to end-users. Global UCR collaboration networks and greater control by local stakeholders over global UCRs may increase active, sustained use of global repositories and yield higher quality results for strategic planning and resource mobilization.

Identifiants

pubmed: 37264335
doi: 10.1186/s12889-023-15964-6
pii: 10.1186/s12889-023-15964-6
pmc: PMC10234678
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1055

Informations de copyright

© 2023. The Author(s).

Références

Science. 2001 Jun 29;292(5526):2434-6
pubmed: 11423619
AIDS. 2002 Dec;16 Suppl 3:S58-65
pubmed: 12685926
BMC Pediatr. 2016 Mar 15;16:41
pubmed: 26979974
BMC Public Health. 2009 Nov 18;9 Suppl 1:S6
pubmed: 19922690
Pharmacoeconomics. 2020 Sep;38(9):995-1005
pubmed: 32596785
PLoS One. 2014 May 06;9(5):e84701
pubmed: 24802593
Int J Tuberc Lung Dis. 2020 Aug 1;24(8):802-810
pubmed: 32912385
Afr J AIDS Res. 2019 Dec;18(4):263-276
pubmed: 31779571
PLoS One. 2021 Apr 22;16(4):e0249076
pubmed: 33886576
Lancet. 2011 Jun 11;377(9782):2031-41
pubmed: 21641026
Afr J AIDS Res. 2019 Dec;18(4):297-305
pubmed: 31779577

Auteurs

Lori A Bollinger (LA)

Avenir Health, Glastonbury, P.O. Box 1337, CT, 06033-6337, Glastonbury, USA. lbollinger@avenirhealth.org.

Joseph Corlis (J)

Center for Health Decision Science, Harvard T.H. Chan School of Public Health, MA, Boston, USA.

Regina Ombam (R)

USAID/KEA Mission Support for Journey to Self-Reliance, Nairobi, Kenya.

Steven Forsythe (S)

Avenir Health, Glastonbury, P.O. Box 1337, CT, 06033-6337, Glastonbury, USA.

Stephen C Resch (SC)

Center for Health Decision Science, Harvard T.H. Chan School of Public Health, MA, Boston, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH